Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation

被引:2
作者
Neumann, NJ [1 ]
Grosse, OJ [1 ]
Ruzicka, T [1 ]
Lehmann, P [1 ]
机构
[1] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany
来源
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 2001年 / 14卷 / 04期
关键词
8-methoxypsoralen; ultraviolet A; penetration kinetics; PUVA bath therapy;
D O I
10.1159/000056349
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Administration of 8-methoxypsoralen (8-MOP) in a dilute bath water solution is an effective therapeutic alternative for systemic application of 8-MOP, avoiding systemic side effects such as nausea and cataractogenesis. The aim of our study was to determine the epicutaneous penetration of 8-MOP in a dilute bath water solution with and without additional UVA irradiation in human skin under in vitro conditions. To simulate the PUVA bath procedure, 8 skin samples were exposed to radioactively labeled 8-MOP in a water solution. After 20 min, the test solution was removed and the skin surface was dried. Immediately after the bath procedure, 4 of the skin samples were irradiated with 0.5 J/cm(2) UVA. During a test period of 15 h, the 8-MOP penetration was observed. In both test groups (with and without UVA irradiation) 8-MOP permeated through all skin layers between 30 min and 1 h after application. Compared to the unirradiated skin samples, the UVA-irradiated skin samples showed a significantly slower increase and a lower maximum of 8-MOP permeation. Following our results, UVA irradiation of 8-MOP-exposed skin samples led to a significantly decreased permeation rate. This might be due to UVA-induced links between 8-MOP molecules and human DNA. In addition, we investigated the levels of radioactivity emitted by tritium-labeled 8-MOP in stratum corneum, epidermis and dermis up to 30 min after 8-MOP bath in two further test groups with and without additional UVA irradiation. The statistical analysis revealed no significant differences between these two test groups. Thus, the levels of radioactivity remained constant in the epidermis and dermis during the test period of 30 min. Since the levels of radioactivity were constant up to 30 min after UVA irradiation, a previously supposed marked loss of 8-MOP concentration might not be responsible for the rapid extinction of observed in vivo photosensitivity within 1 h after PUVA bath observed in vivo in human skin. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 50 条
[31]   Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures [J].
Kitamura, Yohei ;
Namikawa, Hiromi ;
Hayashi, Shujiro ;
Yoshida, Takahiro ;
Suzuki, Toshihiro ;
Hamasaki, Yoichiro ;
Yamazaki, Soji ;
Hatamochi, Atsushi .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (07) :507-513
[32]   The classical photoactivated drug 8-methoxypsoralen and related compounds are effective without UV light irradiation against glioma cells [J].
de Oliveira, Diego Madureira ;
Ferreira Lima, Rute Maria ;
Clarencio, Jorge ;
Velozo, Eudes da Silva ;
de Amorim, Ilza Alves ;
Andrade da Mota, Tales Henrique ;
Costa, Silvia Lima ;
Silva, Fabio Pittella ;
El-Bacha, Ramon dos Santos .
NEUROCHEMISTRY INTERNATIONAL, 2016, 99 :33-41
[33]   Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures [J].
Yohei Kitamura ;
Hiromi Namikawa ;
Shujiro Hayashi ;
Takahiro Yoshida ;
Toshihiro Suzuki ;
Yoichiro Hamasaki ;
Soji Yamazaki ;
Atsushi Hatamochi .
Archives of Dermatological Research, 2009, 301 :507-513
[34]   TREATMENT OF PSORIASIS WITH PSORALENS AND ULTRAVIOLET-A - A DOUBLE-BLIND COMPARISON OF 8-METHOXYPSORALEN AND 5-METHOXYPSORALEN [J].
BERG, M ;
ROS, AM .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 1994, 10 (05) :217-220
[35]   ULTRAVIOLET-LIGHT AND 8-METHOXYPSORALEN INHIBIT EXPRESSION OF ENDOTHELIAL ADHESION MOLECULES [J].
LAING, TJ ;
RICHARDSON, BC ;
TOTH, MB ;
SMITH, EM ;
MARKS, RM .
JOURNAL OF RHEUMATOLOGY, 1995, 22 (11) :2126-2131
[36]   DETERMINATION OF 8-METHOXYPSORALEN KINETICS - A RELEVANT FACTOR IN THE TREATMENT OF PSORIASIS BY PSORALEN PLUS ULTRAVIOLET-A THERAPY [J].
BONNOT, D ;
BEANI, JC ;
BOITARD, M ;
REYMOND, JL ;
BERIEL, H ;
AMBLARD, P .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 1994, 10 (01) :33-37
[37]   Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis [J].
Balogh, A ;
Merkel, U ;
Looks, A ;
Vollandt, R ;
Wollina, U .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1998, 50 (4-6) :397-401
[38]   Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis [J].
Balogh, A ;
Merkel, U ;
Looks, A ;
Vollandt, R ;
Wollina, U .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 1998, 11 (4-5) :258-265
[39]   THE OXIDIZED PRODUCTS OF 8-METHOXYPSORALEN (8-MOP) WITH H2O2-NAOCL [J].
MURAKAMI, N ;
MORIMOTO, T ;
MATSUO, K ;
NAGAI, SI ;
UEDA, T ;
SAKAKIBARA, J ;
MIZUNO, N ;
ESAKI, K .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (10) :2715-2717
[40]   Spectroscopic detection of photoproducts in lecithin model system after 8-methoxypsoralen plus UV-A treatment [J].
Waszkowska, E ;
Zarebska, Z ;
Poznanski, J ;
Zhukov, I .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2000, 55 (2-3) :145-154